ITGAE and neoplasm: The interaction of CD103 with E-cadherin on tumor cells enhances cytokine production by antitumor T cells, and targeting CD103 with blocking antibodies inhibits cytotoxicity of CD103+ T cells towards tumor cells [68,69].